Skip to main navigation

Home
About
Pipeline
Science
For Patients
Jobs
Investors
Contact

News Releases

Site - News & Events

News Releases
Presentations and Events

News Releases

Year

Sep 24, 2021

Leap Therapeutics Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares

Sep 22, 2021

Leap Therapeutics Announces Pricing of $90 million of Common Stock and Pre-Funded Warrants

Sep 21, 2021

Leap Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Sep 16, 2021

Leap Therapeutics Presents Updated Positive Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab at the ESMO Congress

Sep 13, 2021

Leap Therapeutics to Present New Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab at the ESMO 2021 Congress

Sep 07, 2021

Leap Therapeutics to Participate at Two Upcoming Virtual Investor Conferences

Aug 13, 2021

Leap Therapeutics Reports Second Quarter 2021 Financial Results and Upcoming Data Presentation

Jul 26, 2021

Leap Therapeutics to Present at the ESMO 2021 Virtual Congress

Jul 07, 2021

Leap Therapeutics to Present at Ladenburg Thalmann 2021 Virtual Healthcare Conference

Jun 14, 2021

Leap Therapeutics to Present at Raymond James 2021 Virtual Human Health Innovation Conference

Pagination

Current page 1
Page 2
Next page
Last page

Print Page

Email Alerts

Contact Us

© 2021 Leap Therapeutics, Inc.
All Rights Reserved
Terms of Use
Privacy Policy